Belize vs Morocco: Protecting minority investors: Ease of shareholder suits index (0-10)
Belize
60
in 2013
Morocco
60
in 2013
Belize rank
78th
Morocco rank
78th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Belize
- Morocco
How they compare
Belize currently reports 60 against 60 in Morocco, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Belize ahead.
Belize ranks 78th and Morocco ranks 78th of 191 countries.
Belize has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belize | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60 | 10 | 50 | Belize |
| 2010s | 60 | 47.5 | 12.5 | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Belize or Morocco?
- Belize, at 60 against 60 in Morocco as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Belize and Morocco?
- 0, with Belize ahead.
- How many years of comparable data are there for Belize and Morocco?
- 9 years are reported by both, from 2005 to 2013.
- How do Belize and Morocco rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Belize ranks 78th and Morocco ranks 78th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.